| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1157 | 20 | 1044 | 87 | 1059 | 176 | 1071 |
| ERLYTX | 75 | 1 | 52 | 3 | 37 | 7 | 43 |
| GI | 161 | 1 | 52 | 13 | 158 | 26 | 158 |
| GU | 394 | 9 | 470 | 43 | 524 | 93 | 566 |
| LEUK | 161 | 3 | 157 | 16 | 195 | 30 | 183 |
| LUNG | 205 | 2 | 104 | 13 | 158 | 26 | 158 |
| LYMPH | 428 | 9 | 470 | 36 | 438 | 70 | 426 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 116 | 2 | 104 | 16 | 195 | 20 | 122 |
| MULT | 51 | 1 | 52 | 2 | 24 | 3 | 18 |
| OTHER | 43 | 0 | 0 | 1 | 12 | 3 | 18 |
| Total | 2799 | 48 | 2505 | 231 | 2812 | 455 | 2769 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 212 | 4 | 209 | 21 | 256 | 37 | 225 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| GU | 5 | 0 | 0 | 2 | 24 | 3 | 18 |
| LEUK | 616 | 9 | 470 | 57 | 694 | 107 | 651 |
| LUNG | 372 | 9 | 470 | 45 | 548 | 67 | 408 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 15 | 0 | 0 | 2 | 24 | 6 | 37 |
| PEOLC | 67 | 3 | 157 | 3 | 37 | 3 | 18 |
| PREV | 230 | 3 | 157 | 20 | 244 | 28 | 170 |
| SXQOL | 659 | 9 | 470 | 53 | 645 | 102 | 621 |
| Total | 2180 | 38 | 1985 | 204 | 2484 | 355 | 2160 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1157 | 20 | 1044 | 87 | 1059 | 176 | 1071 |
| CCD | 212 | 4 | 209 | 21 | 256 | 37 | 225 |
| ERLYTX | 77 | 1 | 52 | 3 | 37 | 7 | 43 |
| GI | 162 | 1 | 52 | 13 | 158 | 27 | 164 |
| GU | 399 | 9 | 470 | 45 | 548 | 96 | 584 |
| LEUK | 777 | 12 | 626 | 73 | 889 | 137 | 834 |
| LUNG | 577 | 11 | 574 | 58 | 706 | 93 | 566 |
| LYMPH | 429 | 10 | 522 | 37 | 450 | 71 | 432 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 116 | 2 | 104 | 16 | 195 | 20 | 122 |
| MULT | 51 | 1 | 52 | 2 | 24 | 3 | 18 |
| OTHER | 58 | 0 | 0 | 3 | 37 | 9 | 55 |
| PEOLC | 67 | 3 | 157 | 3 | 37 | 3 | 18 |
| PREV | 230 | 3 | 157 | 20 | 244 | 28 | 170 |
| SXQOL | 659 | 9 | 470 | 53 | 645 | 102 | 621 |
| Total | 4979 | 86 | 4489 | 435 | 5297 | 810 | 4929 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 708 | 13 | 678 | 50 | 609 | 97 | 590 |
| ERLYTX | 53 | 1 | 52 | 3 | 37 | 5 | 30 |
| GI | 124 | 1 | 52 | 9 | 110 | 21 | 128 |
| GU | 289 | 5 | 261 | 28 | 341 | 61 | 371 |
| LEUK | 99 | 0 | 0 | 7 | 85 | 15 | 91 |
| LUNG | 130 | 1 | 52 | 8 | 97 | 19 | 116 |
| LYMPH | 279 | 6 | 313 | 23 | 280 | 45 | 274 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 66 | 2 | 104 | 10 | 122 | 11 | 67 |
| MULT | 21 | 1 | 52 | 2 | 24 | 2 | 12 |
| OTHER | 43 | 0 | 0 | 1 | 12 | 3 | 18 |
| Total | 1820 | 30 | 1564 | 142 | 1729 | 280 | 1703 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 156 | 1 | 52 | 15 | 183 | 26 | 158 |
| ERLYTX | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| GI | 1 | 0 | 0 | 0 | 0 | 1 | 6 |
| GU | 5 | 0 | 0 | 2 | 24 | 3 | 18 |
| LEUK | 250 | 4 | 209 | 23 | 280 | 36 | 219 |
| LUNG | 228 | 7 | 365 | 31 | 377 | 44 | 268 |
| LYMPH | 1 | 1 | 52 | 1 | 12 | 1 | 6 |
| OTHER | 15 | 0 | 0 | 2 | 24 | 6 | 37 |
| PEOLC | 55 | 3 | 157 | 3 | 37 | 3 | 18 |
| PREV | 230 | 3 | 157 | 20 | 244 | 28 | 170 |
| SXQOL | 480 | 6 | 313 | 36 | 438 | 75 | 457 |
| Total | 1423 | 25 | 1305 | 133 | 1619 | 223 | 1357 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 905 | 18 | 939 | 74 | 901 | 143 | 871 |
| CCD | 171 | 1 | 52 | 11 | 134 | 22 | 134 |
| ERLYTX | 55 | 1 | 52 | 3 | 37 | 5 | 30 |
| GI | 138 | 0 | 0 | 10 | 122 | 27 | 164 |
| GU | 328 | 5 | 261 | 31 | 377 | 69 | 420 |
| LEUK | 352 | 4 | 209 | 30 | 365 | 51 | 310 |
| LUNG | 387 | 8 | 417 | 39 | 475 | 69 | 420 |
| LYMPH | 280 | 7 | 365 | 24 | 292 | 46 | 280 |
| MELAN | 8 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 66 | 2 | 104 | 10 | 122 | 11 | 67 |
| MULT | 42 | 0 | 0 | 4 | 49 | 10 | 61 |
| OTHER | 125 | 0 | 0 | 3 | 37 | 8 | 49 |
| PEOLC | 56 | 0 | 0 | 3 | 37 | 3 | 18 |
| PREV | 230 | 3 | 157 | 20 | 244 | 28 | 170 |
| SXQOL | 480 | 6 | 313 | 36 | 438 | 75 | 457 |
| Total | 3623 | 55 | 2869 | 299 | 3642 | 568 | 3457 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 995 | 20 | 1044 | 83 | 1011 | 165 | 1004 |
| ERLYTX | 71 | 1 | 52 | 3 | 37 | 7 | 43 |
| GI | 96 | 0 | 0 | 10 | 122 | 18 | 110 |
| GU | 285 | 9 | 470 | 34 | 414 | 68 | 414 |
| LEUK | 132 | 3 | 157 | 15 | 183 | 26 | 158 |
| LUNG | 181 | 2 | 104 | 12 | 146 | 24 | 146 |
| LYMPH | 355 | 9 | 470 | 34 | 414 | 59 | 359 |
| MMYEL | 103 | 2 | 104 | 15 | 183 | 19 | 116 |
| MULT | 51 | 1 | 52 | 2 | 24 | 3 | 18 |
| Total | 2269 | 47 | 2453 | 208 | 2534 | 389 | 2368 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1898 | 37 | 1931 | 161 | 1960 | 298 | 1814 |
| AFFIL | 126 | 1 | 52 | 3 | 37 | 7 | 43 |
| CCOP/NCORP | 1219 | 17 | 887 | 111 | 1351 | 198 | 1205 |
| Non-SWOG | 1736 | 31 | 1618 | 160 | 1948 | 307 | 1869 |
| Total | 4979 | 86 | 4488 | 435 | 5296 | 810 | 4931 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LEUK | S2507 | ALL/ALAL, KMT2A-trans, Blina +/- Revumenib | 1 | Y | 22-SEP-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| OTHER | NRGGY026 | Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE | 1 | E | 29-SEP-26 |
| OTHER | NRGBN003 | Mening, Grd II, Observation vs Irradiation | 1 | E | 28-SEP-26 |
| OTHER | NRGBN003 | Mening, Grd II, Observation vs Irradiation | 2 | E | 28-SEP-26 |
| SXQOL | NRG-CC013 | HN Squamous Cell, Rec Chemo, BMX | 1 | E | 23-SEP-26 |
| OTHER | NRGHN009 | HN, RT + HD Cisp vs RT + LD Cisp for SCCHN | 1 | E | 02-OCT-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 19 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 11 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 9 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 9 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 9 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 7 |
| CCD | S2417CD | Colrec Surv, Follow-up w/ CTAC site | 1 | 4 |
| GU | S2419 | Renal, adv clear cell, IO +/- Biotx, BIOFRONT | 1 | 4 |
| GU | S2427 | Blad, MIBC, RT + Pembrolizumab | 1 | 4 |
| PEOLC | S1501 | Breast Stg IV, Card Tox Obs and w/ Carvedilol | 2 | 3 |